3,4,5-trimethoxy-N-[(exo)-9-[[4-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]-9-azabicyclo[3.3.1]nonan-3-yl]benzamide

ID: ALA4637126

Chembl Id: CHEMBL4637126

PubChem CID: 156012542

Max Phase: Preclinical

Molecular Formula: C27H30F3N3O4S

Molecular Weight: 549.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)N[C@@H]2C[C@H]3CCC[C@@H](C2)N3Cc2nc3c(C(F)(F)F)cccc3s2)cc(OC)c1OC

Standard InChI:  InChI=1S/C27H30F3N3O4S/c1-35-20-10-15(11-21(36-2)25(20)37-3)26(34)31-16-12-17-6-4-7-18(13-16)33(17)14-23-32-24-19(27(28,29)30)8-5-9-22(24)38-23/h5,8-11,16-18H,4,6-7,12-14H2,1-3H3,(H,31,34)/t16-,17-,18+

Standard InChI Key:  OZAGNFAFPKLYFB-NNZMDNLPSA-N

Alternative Forms

  1. Parent:

    ALA4637126

    ---

Associated Targets(Human)

CXCR6 Tchem C-X-C chemokine receptor type 6 (264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-HEP1 (1155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cxcr6 C-X-C chemokine receptor type 6 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 549.62Molecular Weight (Monoisotopic): 549.1909AlogP: 5.66#Rotatable Bonds: 7
Polar Surface Area: 72.92Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.32CX LogP: 4.39CX LogD: 4.12
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.41Np Likeness Score: -1.08

References

1. Peddibhotla S, Hershberger PM, Jason Kirby R, Sugarman E, Maloney PR, Hampton Sessions E, Divlianska D, Morfa CJ, Terry D, Pinkerton AB, Smith LH, Malany S..  (2020)  Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma.,  30  (4): [PMID:31882297] [10.1016/j.bmcl.2019.126899]

Source